detection and quantification of hepatitis b virus genomes in peripheral blood mononuclear cells of chronic hepatitis b virus infection, cirrhosis, and hepatocellular carcinoma patients

Background: several studies have revealed that the hepatitis b virus (hbv) exists in peripheral blood mononuclear cells (pbmcs). it remains poorly understood whether hbv dna and covalently closed circular dna (cccdna) can emerge in pbmcs of patients with different stages of hbv infection. objectives: this study aimed to compare the detection of hbv dna and quantification and presence of cccdna within pbmc from patients with chronic hepatitis b (chb), cirrhosis, and hepatocellular carcinoma (hcc). methods: the present study was conducted on 120 participants (30 chb patients, 30 cirrhosis patients, 30 hcc patients, and 30 healthy controls) from tehran, iran. hbv serological markers were tested by enzyme-linked immunosorbent assay (elisa). pbmcs of all individuals were assayed for hbv dna detection, quantification, and the presence of cccdna. results: of 90 hbv patients, 58 (64.4%) were positive for hbv dna in pbmcs. hbv dna was detected in pbmcs isolated from 13/30 chb, 20/30 cirrhosis, and 25/30 hcc patients. in addition, 6 (20%) chb, 13 (43.3%) cirrhosis, and 16 (15.3%) hcc patients were cccdna positive. the hbv viral loads in serums were statistically higher than the hbv viral loads of pbmcs (p < 0.001). a positive correlation was found between hbv dna loads in serums and pbmcs of patients. moreover, hbv dna quantity of serums and pbmcs showed a significant association in terms of hepatitis b e antigen (hbeag) status. conclusions: hbv quantity in pbmcs correlated with serum hbv viral loads. hbv genomes in pbmcs may be a risk factor for hbv disease progression.